These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28258398)

  • 1. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.
    Drummond E; Nayak S; Faustin A; Pires G; Hickman RA; Askenazi M; Cohen M; Haldiman T; Kim C; Han X; Shao Y; Safar JG; Ueberheide B; Wisniewski T
    Acta Neuropathol; 2017 Jun; 133(6):933-954. PubMed ID: 28258398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer's Disease.
    Noor A; Zafar S; Shafiq M; Younas N; Siegert A; Mann FA; Kruss S; Schmitz M; Dihazi H; Ferrer I; Zerr I
    Mol Neurobiol; 2022 Jan; 59(1):17-34. PubMed ID: 34618331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of Amyloid Plaques and Neurofibrillary Tangles from Archived Alzheimer's Disease Tissue Using Laser-Capture Microdissection for Downstream Proteomics.
    Drummond E; Nayak S; Pires G; Ueberheide B; Wisniewski T
    Methods Mol Biol; 2018; 1723():319-334. PubMed ID: 29344869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.
    Drummond E; Kavanagh T; Pires G; Marta-Ariza M; Kanshin E; Nayak S; Faustin A; Berdah V; Ueberheide B; Wisniewski T
    Acta Neuropathol Commun; 2022 Apr; 10(1):53. PubMed ID: 35418158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
    Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    Bastrup J; Hansen KH; Poulsen TBG; Kastaniegaard K; Asuni AA; Christensen S; Belling D; Helboe L; Stensballe A; Volbracht C
    J Alzheimers Dis; 2021; 79(1):249-265. PubMed ID: 33252074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly Progressive Alzheimer's Disease: Contributions to Clinical-Pathological Definition and Diagnosis.
    Abu-Rumeileh S; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 63(3):887-897. PubMed ID: 29710713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
    Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser capture microdissection of fluorescently labeled amyloid plaques from Alzheimer's disease brain tissue for mass spectrometric analysis.
    Nijholt DA; Stingl C; Luider TM
    Methods Mol Biol; 2015; 1243():165-73. PubMed ID: 25384745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
    Dickson TC; Saunders HL; Vickers JC
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic and Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    Bastrup J; Kastaniegaard K; Asuni AA; Volbracht C; Stensballe A
    J Alzheimers Dis; 2020; 73(1):393-411. PubMed ID: 31771055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.
    Yang J; Zhang R; Shi C; Mao C; Yang Z; Suo Z; Torp R; Xu Y
    J Alzheimers Dis; 2017; 57(1):157-169. PubMed ID: 28222512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calsyntenin-3 C-terminal fragment accumulates in dystrophic neurites surrounding aβ plaques in tg2576 mouse and Alzheimer disease brains: its neurotoxic role in mediating dystrophic neurite formation.
    Uchida Y; Gomi F; Murayama S; Takahashi H
    Am J Pathol; 2013 May; 182(5):1718-26. PubMed ID: 23499467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer's disease.
    Shafiq M; Zafar S; Younas N; Noor A; Puig B; Altmeppen HC; Schmitz M; Matschke J; Ferrer I; Glatzel M; Zerr I
    Mol Neurodegener; 2021 Feb; 16(1):11. PubMed ID: 33618749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease.
    Gomez-Arboledas A; Davila JC; Sanchez-Mejias E; Navarro V; Nuñez-Diaz C; Sanchez-Varo R; Sanchez-Mico MV; Trujillo-Estrada L; Fernandez-Valenzuela JJ; Vizuete M; Comella JX; Galea E; Vitorica J; Gutierrez A
    Glia; 2018 Mar; 66(3):637-653. PubMed ID: 29178139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
    Meyer-Luehmann M; Spires-Jones TL; Prada C; Garcia-Alloza M; de Calignon A; Rozkalne A; Koenigsknecht-Talboo J; Holtzman DM; Bacskai BJ; Hyman BT
    Nature; 2008 Feb; 451(7179):720-4. PubMed ID: 18256671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.